drugset / Trial / NCT06339216
A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.
NaSingle-groupOpen-labelTreatment
Summary
Phase II Clinical Study of Adebrelimab Combined with Apatinib and Paclitaxel for Injection(Albumin Bound) as Second-line Therapy in Patients with Advanced Gastric Cancer Previously Treated with Immunotherapy
Timeline
- Start
- 2024-03-20
- Primary completion
- 2024-12-30
- Completion
- 2026-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adebrelimab | Monoclonal antibody | 1200 mg | Intravenous |
| Subject | Paclitaxel | Small molecule | 250 mg/m2 | Intravenous |
| Subject | Rivoceranib | Small molecule | 250 mg | Oral |